Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

210 insider filings · Latest: Aug 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 26, 2026Mar 27 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$535.81$5.1M40,513(D)

View →

Mar 26, 2026Mar 27 8:31 PMJames EdgemondCFO AND TREASURER
Sale
10,000$535.90$5.4M18,876(D)

View →

Mar 25, 2026Mar 26 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$543.73$5.2M40,513(D)

View →

Mar 26, 2026Mar 26 8:34 PMTommy G ThompsonDirector
Sale
2,000$539.17$1.1M8,480(D)

View →

Mar 26, 2026Mar 26 8:04 PMTOMMY THOMPSON
Proposed Sale
2,000$539.17$1.1M

View →

Mar 24, 2026Mar 25 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$529.36$5.0M40,513(D)

View →

Mar 23, 2026Mar 24 8:33 PMJames EdgemondCFO AND TREASURER
Sale
10,000$527.48$5.3M18,876(D)

View →

Mar 23, 2026Mar 24 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$527.01$5.0M40,513(D)

View →

Mar 23, 2026Mar 24 8:31 PMJudy D. OlianDirector
Sale
200$530.00$106.0K4,245(D)

View →

Mar 23, 2026Mar 23 8:35 PMJAMES C EDGEMOND
Proposed Sale
120,000$524.28$62.9M

View →

Mar 20, 2026Mar 23 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$524.99$5.0M40,513(D)

View →

Mar 23, 2026Mar 23 8:01 PMJUDY OLIAN
Proposed Sale
200$530.00$106.0K

View →

Mar 19, 2026Mar 20 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$528.83$5.0M40,513(D)

View →

Mar 18, 2026Mar 19 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$529.59$5.0M40,513(D)

View →

Mar 19, 2026Mar 19 8:30 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$529.95$4.4M45,172(D)

View →

Mar 19, 2026Mar 19 8:05 PMPAUL MAHON
Proposed Sale
8,300$529.95$4.4M

View →

Mar 17, 2026Mar 18 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$536.75$5.1M40,513(D)

View →

Mar 16, 2026Mar 17 9:11 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$533.90$5.1M40,513(D)

View →

Mar 17, 2026Mar 17 8:56 PMJan MalcolmDirector
Sale
45$533.51$24.0K125(D)

View →

Mar 17, 2026Mar 17 8:05 PMJAN MALCOLM
Proposed Sale
45$533.51$24.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,2201,220(D)

View →

← Previous

Page 11 of 11